Antihyperglycemic effects of three extracts from Momordica charantia.
about
Traditional chinese medicine in treatment of metabolic syndromeNovel nutraceutic therapies for the treatment of metabolic syndromeAntidiabetic potential of some less commonly used plants in traditional medicinal systems of India and NigeriaBeneficial role of bitter melon supplementation in obesity and related complications in metabolic syndromeWild bitter gourd protects against alcoholic fatty liver in mice by attenuating oxidative stress and inflammatory responses.Gene cloning and expression of a novel hypoglycaemic peptide from Momordica charantia.Teratogenic effect of the water extract of bitter gourd (Momordica charantia) on the Sprague Dawley ratsLipid lowering effects of Momordica charantia (Bitter Melon) in HIV-1-protease inhibitor-treated human hepatoma cells, HepG2.Lower hypoglycemic but higher antiatherogenic effects of bitter melon than glibenclamide in type 2 diabetic patients.Antiglycation and Antioxidant Properties of Momordica charantiaEvaluation of Antidiabetic Activity and Associated Toxicity of Artemisia afra Aqueous Extract in Wistar Rats.Traditional medicinal plants used for the treatment of diabetes in rural and urban areas of Dhaka, Bangladesh--an ethnobotanical survey.Development of an antidiabetic formulation (ADJ6) and its inhibitory activity against α-amylase and α-glucosidaseAnti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review.Natural products in anti-obesity therapy.Interactions between herbs and antidiabetics: an overview of the mechanisms, evidence, importance, and management.Studies on the antidiabetic activities of Momordica charantia fruit juice in streptozotocin-induced diabetic rats.Momordica charantia: a popular health-promoting vegetable with multifunctionality.In vitro anti-diabetic activities and chemical analysis of polypeptide-k and oil isolated from seeds of Momordica charantia (bitter gourd).Momordica charantia (bitter melon) reduces plasma apolipoprotein B-100 and increases hepatic insulin receptor substrate and phosphoinositide-3 kinase interactions.Neutraceutical approaches to control diabetes: A natural requisite approach.In vivo Antidiabetic and Antioxidant Potential of Stephania hernandifolia in Streptozotocin-Induced-Diabetic Rats.Effect of Alpinia calcarata on glucose uptake in diabetic rats-an in vitro and in vivo model.A case of atrial fibrillation due to Momordica charantia (bitter melon).Effect of Momordica charantia fruit extract on vascular complication in type 1 diabetic rats.Protective effect of Momordica charantia fruit extract on hyperglycaemia-induced cardiac fibrosis.Hypoglycemic and hypolipidemic effects of different parts and formulations of bitter gourd (Momordica Charantia).Hypoglycaemic activity of saponin fraction extracted from Momordica charantia in PEG/salt aqueous two-phase systems.Reduced adiposity in bitter melon (Momordica charantia) fed rats is associated with lower tissue triglyceride and higher plasma catecholamines.Evaluation of hypoglycemic and antioxidative effects of synthesized peptide MC62.Antidiabetic effects of Momordica charantia (bitter melon) and its medicinal potency.Recent Advances in Momordica charantia: Functional Components and Biological Activities.The beneficial effects of Momordica charantia (bitter gourd) on wound healing of rabbit skin.Structural Alteration of Gut Microbiota during the Amelioration of Human Type 2 Diabetes with Hyperlipidemia by Metformin and a Traditional Chinese Herbal Formula: a Multicenter, Randomized, Open Label Clinical Trial.Rejuvenating of Kidney Tissues on Alloxan Induced Diabetic Mice under the Effect ofMomordica charantia
P2860
Q24657961-97650A14-8DD7-4266-BE67-37F08B4B8B43Q26748558-54D447D0-E0C8-49C3-BAAD-6EC3B4B1F1D2Q26781658-7B45FA03-2FE7-4836-A45D-2BBB348E4C00Q28081950-FE6F90BC-7BBC-4765-BFCC-E1E1E372A10FQ34040303-8ACA10AC-D55B-4A98-80FE-D185AFED3030Q34188462-244D658D-A241-40FE-878E-738CFA0F1FA8Q34421588-8000A414-6B67-48EC-B295-EC2B52E03AC7Q35546434-B065465A-11A6-4B71-99BD-874F520AFDCAQ35562587-E6BEEE0A-6777-43CA-9704-3AD45DDFF059Q36101386-FB3D36F8-9CCD-409F-A241-F8690D61B1D1Q36942780-B383FD68-F705-4762-A9AB-35DAC9395FC4Q36985659-AD268994-A772-4346-9A74-DA149E7D4976Q37074633-885550F1-FE43-401E-9874-3C7271297AACQ37613790-68A015AC-EE4C-4CAA-900C-789FF1011B15Q37899052-4FE929E1-43B5-4EC7-AB5D-753EA78C9740Q38283110-43B851CE-0CAB-4A14-9665-245877DB0884Q38773379-5CA9CA24-2C56-4C1B-A665-BB27F5C6DEA0Q39285044-938583C2-BD76-4432-8166-1735ADEFE01CQ39299130-2E60153C-B72E-4821-AC4D-FCEABDDFB766Q39299548-1E7C3F10-AEB7-4F58-BAF9-82900E68F28AQ41831630-A6F8E2D5-F88E-4F04-ACC2-65883485C4E9Q41857384-7F3BFAEA-7DAE-4915-A2DB-AFDE594F3CA3Q42008049-B9AE9C94-9765-4BF7-BCB8-18FCD75062CCQ42848886-AD993CEF-2937-40F6-B05D-6C4C41A6DE89Q42956451-62E01B57-D53E-4CB3-8015-27A1E2CA7137Q42964167-62F37221-BCCD-40E7-BBD3-A0199BC7F6E6Q46122251-9D205BC1-9B2B-4611-908C-8084C50B0366Q46316639-64784444-A9A6-477B-9523-45AEF9AF3BD7Q46563687-6404840E-E0A0-4333-8A8A-97D370D0EC44Q46770130-B9BF396E-E02C-4CCD-94DC-0019F36CBBE1Q47132559-9014EF13-49E3-48F1-85D7-672BD5D8FFA3Q47356636-37726867-4A09-47DE-86E5-71995D665D00Q53156016-783427BF-21B4-4A34-9092-C19258DD73B9Q55400264-3FFC2EA3-D46D-454A-BF35-7357646B8160Q59051404-FE05F669-17A9-4792-A3B8-08490933DDEF
P2860
Antihyperglycemic effects of three extracts from Momordica charantia.
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh-hant
name
Antihyperglycemic effects of three extracts from Momordica charantia.
@en
Antihyperglycemic effects of three extracts from Momordica charantia.
@nl
type
label
Antihyperglycemic effects of three extracts from Momordica charantia.
@en
Antihyperglycemic effects of three extracts from Momordica charantia.
@nl
prefLabel
Antihyperglycemic effects of three extracts from Momordica charantia.
@en
Antihyperglycemic effects of three extracts from Momordica charantia.
@nl
P2093
P1476
Antihyperglycemic effects of three extracts from Momordica charantia.
@en
P2093
A C Suthar
Jaspreet Virdi
M K Biyani
M M Banavalikar
S Sivakami
P304
P356
10.1016/S0378-8741(03)00184-3
P577
2003-09-01T00:00:00Z